H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodTop Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| KITE PHARMA INC. | 9 | $56,560 | $49,192 - $57,760 | 100.0% |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 3 | $77,000 | $75,000 - $85,000 | 100.0% |
| Atara Biotherapeutics, Inc. | 1 | $96,000 | $96,000 - $96,000 | 100.0% |
| Takeda Development Center Americas, Inc. | 1 | $80,000 | $80,000 - $80,000 | 0.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| I | 7 | $56,560 | $49,192 - $77,501 |
| II | 5 | $56,701 | $49,192 - $84,490 |
| Unspecified | 3 | $80,000 | $75,000 - $96,000 |
| Senior | 1 | $85,000 | $85,000 - $85,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Philadelphia | PA | 3 | $77,000 |
| El Segundo | CA | 3 | $49,192 |
| Santa Monica | CA | 3 | $56,701 |
| Seattle | WA | 2 | $80,995 |
| Urbana | MD | 2 | $56,560 |
| Santa Clara | CA | 1 | $96,000 |
| Los Angeles | CA | 1 | $56,701 |
These roles are variations of Cell Therapy Specialist I with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| Cell Therapy Specialist I | 13 | $53,916 | |
| Cell Therapy Specialist II | 6 | $66,747 | |
| Cell Therapy Specialist | Unspecified | 3 | $83,667 |
| Cell Therapy Specialist Senior | 1 | $85,000 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 2 | $49,192 | 100.0% |
| 2022 | 2 | $64,531 | 100.0% |
| 2023 | 4 | $81,250 | 100.0% |
| 2024 | 1 | $57,760 | 100.0% |
| 2025 | 3 | $56,701 | 100.0% |
| 2026 | 4 | $68,280 | 75.0% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| KITE PHARMA INC. | 9 | $56,560 | 100.0% |
| TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 3 | $77,000 | 100.0% |
| Atara Biotherapeutics, Inc. | 1 | $96,000 | 100.0% |
| Takeda Development Center Americas, Inc. | 1 | $80,000 | 0.0% |